North central cancer treatment group-Mayo clinic trials in colon cancerO'CONNELL, Michael J.Seminars in oncology. 2001, Vol 28, Num 1, pp 4-8, issn 0093-7754, SUP1Conference Paper

Near-infrared resonance Raman excitation profile studies of single-walled carbon nanotube intertube interactions: A direct comparison of bundled and individually dispersed HiPco nanotubesO'CONNELL, Michael J; SIVARAM, Saujan; DOORN, Stephen K et al.Physical review B. Condensed matter and materials physics. 2004, Vol 69, Num 23, pp 235415.1-235415.15, issn 1098-0121Article

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus LeucovorinO'CONNELL, Michael J; LAVERY, Ian; COWENS, J. Wayne et al.Journal of clinical oncology. 2010, Vol 28, Num 25, pp 3937-3944, issn 0732-183X, 8 p.Article

Polyelectrolyte platform for sensitive detection of biological analytes via reversible fluorescence quenchingO'CONNELL, Michael J; CHAN, Candace K; WENGUANG LI et al.Polymer (Guildford). 2007, Vol 48, Num 26, pp 7582-7589, issn 0032-3861, 8 p.Article

Dealing with a deluge of data : An assessment of adverse event data on north central cancer treatment group trialsMAHONEY, Michelle R; SARGENT, Daniel J; O'CONNELL, Michael J et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9275-9281, issn 0732-183X, 7 p.Article

Early detection of toxicity and adjustment of ongoing clinical trials: The history and performance of the North Central Cancer Treatment Group's Real-Time Toxicity Monitoring ProgramGOLDBERG, Richard M; SARGENT, Daniel J; MORTON, Roscoe F et al.Journal of clinical oncology. 2002, Vol 20, Num 23, pp 4591-4596, issn 0732-183X, 6 p.Article

A simple stratification factor prognostic for survival in advanced cancer : the good/bad/uncertain indexSLOAN, Jeff A; LOPRINZI, Charles L; WIESENFELD, Martin et al.Journal of clinical oncology. 2001, Vol 19, Num 15, pp 3539-3546, issn 0732-183XArticle

Impact of surgical and pathologic variables in rectal cancer : a United States community and cooperative group reportSTOCCHI, Luca; NELSON, Heidi; SARGENT, Daniel J et al.Journal of clinical oncology. 2001, Vol 19, Num 18, pp 3895-3902, issn 0732-183XArticle

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT DatabaseQIAN SHI; ANDRE, Thierry; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 29, pp 3656-3663, issn 0732-183X, 8 p.Article

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset AnalysesYOTHERS, Greg; O'CONNELL, Michael J; ALLEGRA, Carmen J et al.Journal of clinical oncology. 2011, Vol 29, Num 28, pp 3768-3774, issn 0732-183X, 7 p.Article

The interaction between threonine and avilamycin on piglet performance and diet digestibility post weaningO'CONNELL, Michael J; CALLAN, James J; O'DOHERTY, John V et al.Journal of the science of food and agriculture. 2006, Vol 86, Num 2, pp 191-196, issn 0022-5142, 6 p.Article

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: Findings from the intergroup 0114 studyMEYERHARDT, Jeffrey A; TEPPER, Joel E; MACDONALD, John S et al.Journal of clinical oncology. 2004, Vol 22, Num 1, pp 166-174, issn 0732-183X, 9 p.Article

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients With locally advanced colon cancerALLEGRA, Carmen J; PARR, Allyson L; KUGLER, John W et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1735-1743, issn 0732-183XArticle

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal CancerSLOAN, Jeff A; GOLDBERG, Richard M; SARGENT, Daniel J et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1491-1498, issn 0732-183XArticle

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Authors' replyERLICHMAN, Charles; GOLDBERG, Richard M; MILLER, Langdon L et al.The New England journal of medicine. 2001, Vol 344, Num 4, pp 305-307, issn 0028-4793Article

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04O'CONNELL, Michael J; COLANGELO, Linda H; PARDA, David S et al.Journal of clinical oncology. 2014, Vol 32, Num 18, pp 1927-1934, issn 0732-183X, 8 p.Conference Paper

Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 TrialALLEGRA, Carmen J; YOTHERS, Greg; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 3, pp 359-364, issn 0732-183X, 6 p.Article

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive ValueGAVIN, Patrick G; COLANGELO, Linda H; BLACKMON, Nicole L et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6531-6541, issn 1078-0432, 11 p.Article

Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data SetDE GRAMONT, Aimery; HUBBARD, Joleen; BLANKE, Charles D et al.Journal of clinical oncology. 2010, Vol 28, Num 3, pp 460-465, issn 0732-183X, 6 p.Article

Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07ZAMBONI, Beth A; YOTHERS, Greg; CHOI, Mehee et al.Journal of clinical oncology. 2010, Vol 28, Num 15, pp 2544-2548, issn 0732-183X, 5 p.Article

Obesity Is an Independent Prognostic Variable in Colon Cancer SurvivorsSINICROPE, Frank A; FOSTER, Nathan R; SARGENT, Daniel J et al.Clinical cancer research (Print). 2010, Vol 16, Num 6, pp 1884-1893, issn 1078-0432, 10 p.Article

Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group InvestigationHILLMAN, Shauna L; AN, Ming-Wen; O'CONNELL, Michael J et al.Journal of clinical oncology. 2009, Vol 27, Num 19, pp 3205-3210, issn 0732-183X, 6 p.Article

Impact of number of nodes retrieved on outcome in patients with rectal cancerTEPPER, Joel E; O'CONNELL, Michael J; NIEDZWIECKI, Donna et al.Journal of clinical oncology. 2001, Vol 19, Num 1, pp 157-163, issn 0732-183XArticle

Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant TrialsYOTHERS, Greg; SARGENT, Daniel J; WOLMARK, Norman et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 20, pp 1498-1506, issn 0027-8874, 9 p.Article

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08ALLEGRA, Carmen J; YOTHERS, Greg; O'REILLY, Seamus et al.Journal of clinical oncology. 2011, Vol 29, Num 1, pp 11-16, issn 0732-183X, 6 p.Article